Demographics | Cases n = 1960 | Controls n = 8377 |
---|---|---|
Women (%) | 801 (41) | 346 (41) |
Year of birth median (Q1,Q3) | 1979 (1975, 1984) | 1979 (1975, 1984) |
Age at first AS diagnosis median (Q1, Q3) | 27 (22, 30) | NA |
Living in same county at time of matching and at birth | 1299 (66) | 5571 (67) |
AS-related inflammatory diseasesa | ||
Anterior uveitis (%) | 337 (17) | 22 (0) |
Inflammatory bowel disease (%) | 108 (6) | 58 (1) |
Psoriasis (%) | 89 (5) | 49 (1) |
Any of the manifestations above (%) | 496 (25) | 127 (2) |
Rheumatic diagnoses before first AS diagnosisb | ||
Spondyloarthritis diagnosisc | 627 (32) | NA |
Any rheumatic diagnosisd | 630 (32) | NA |
Pharmacological treatment in 2011e | ||
TNF-alpha inhibitor (%) | 494 (25) | NA |
Methotrexate (%) | 161 (8) | NA |
Sulphasalazine (%) | 217 (11) | NA |
Any of the treatments above (%) | 700 (36) | NA |
Years of formal of education in 2008f | ||
0–9 years | 309 (16) | 1160 (14) |
10–12 years | 880 (45) | 3705 (44) |
>12 years | 679 (35) | 2993 (36) |
Disposable income in 2008 £ mean (SD)g | 16378 (6797) | 16768 (7050) |
Maternal diabetes (%)h | 12 (0.6) | 36 (0.4) |